[1] 马丽媛,吴亚哲,王文,等.《中国心血管病报告2017》要点解读[J].中国心血管杂志,2018,23(1):3-6.
[2] SIMARD T, HIBBERT B, RAMIREZ FD, et al. The evolution of coronary stents: a brief review. Can J Cardiol. 2014;30(1):35-45.
[3] 谢秀峰,张越,曲泽.药物洗脱球囊和药物洗脱支架对支架内再狭窄的疗效比较[J].中国组织工程研究,2020,24(4):555-560.
[4] 姚雯,赵金河.冠心病介入治疗术后再狭窄防治的研究进展[J].中西医结合心脑血管病杂志,2018,16(23):3456-3458.
[5] ZHANG J, GAO F, NI T, et al. Linc-POU3F3 is overexpressed in in-stent restenosis patients and induces VSMC phenotypic transformation via POU3F3/miR-449a/KLF4 signaling pathway. Am J Transl Res. 2019; 11(7):4481-4490.
[6] GAO Y, ZHU P, XU SF, et al. Ginsenoside Re inhibits PDGF-BB-induced VSMC proliferation via the eNOS/NO/cGMP pathway. Biomed Pharmacother. 2019;115:108934.
[7] 罗靖莹,郭阳,黄玮玮,等.间充质干细胞传递线粒体对肺微血管内皮细胞的修复作用[J].医学研究生学报,2019,32(9):931-936.
[8] NAKAZAKI M, OKA S, SASAKI M, et al. Prevention of neointimal hyperplasia induced by an endovascular stent via intravenous infusion of mesenchymal stem cells. J Neurosurg. 2019;133(6):1-13.
[9] ASAHARA T, MUROHARA T, SULLIVAN A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275(5302): 964-967.
[10] BRIASOULIS A, TOUSOULIS D, ANTONIADES C, et al. The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development. Cardiovasc Ther. 2011;29(2): 125-139.
[11] IKUTOMI M, SAHARA M, NAKAJIMA T, et al. Diverse contribution of bone marrow-derived late-outgrowth endothelial progenitor cells to vascular repair under pulmonary arterial hypertension and arterial neointimal formation. J Mol Cell Cardiol. 2015;86:121-135.
[12] XU RW, ZHANG WJ, ZHANG JB, et al. A Preliminary Study of the Therapeutic Role of Human Early Fetal Aorta-derived Endothelial Progenitor Cells in Inhibiting Carotid Artery Neointimal Hyperplasia. Chin Med J (Engl). 2015;128(24):3357-3362.
[13] LIU NM, SIU KL, YOUN JY, et al. Attenuation of neointimal formation with netrin-1 and netrin-1 preconditioned endothelial progenitor cells. J Mol Med (Berl). 2017;95(3):335-348.
[14] 曾贵荣,罗桂芳,周仕达,等.内皮祖细胞对实验兔动脉粥样硬化再狭窄模型调控功能的研究[J].中国药理学与毒理学杂志,2016, 30(10):1005.
[15] 丁蓉蓉,赵国峰,许荣睿,等.携人血栓调节蛋白基因内皮祖细胞预防动脉成形术后再狭窄[J].中华实验外科杂志,2017,34(5):740-743.
[16] BARSOTTI MC, DI STEFANO R, SPONTONI P, et al. Role of endothelial progenitor cell mobilization after percutaneous angioplasty procedure. Curr Pharm Des. 2009;15(10):1107-1122.
[17] HU A, HUANG J, LI S, et al. Involvement of stromal cell-derived factor-1α (SDF-1α), stem cell factor (SCF), fractalkine (FKN) and VEGF in TSG protection against intimal hyperplasia in rat balloon injury. Biomed Pharmacother. 2019;110:887-894.
[18] KLOMP M, BEIJK MA, DE WINTER RJ. Genous endothelial progenitor cell-capturing stent system: a novel stent technology. Expert Rev Med Devices. 2009;6(4):365-375.
[19] DUAN Y, YU S, XU P, et al. Co-immobilization of CD133 antibodies, vascular endothelial growth factors, and REDV peptide promotes capture, proliferation, and differentiation of endothelial progenitor cells. Acta Biomater. 2019;96:137-148.
[20] XU WY, TANG WL, YUAN M, et al. The Adverse Events Rate of Endothelial Progenitor Cell Capturing Stent in the Treatment of CAD Patients. Comb Chem High Throughput Screen. 2018;21(10):725-733.
[21] BEREBICHEZ-FRIDMAN R, MONTERO-OLVERA PR. Sources and Clinical Applications of Mesenchymal Stem Cells: State-of-the-art review. Sultan Qaboos Univ Med J. 2018;18(3):e264-e277.
[22] 王俊力,许慧芳,冯莉,等.不同组织来源间充质干细胞向血管内皮细胞诱导分化的研究与进展[J].中国组织工程研究,2016,20(36): 5466-5472.
[23] ISO Y, USUI S, TOYODA M, et al. Bone marrow-derived mesenchymal stem cells inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia after arterial injury in rats. Biochem Biophys Rep. 2018;16:79-87.
[24] SONG BW, KIM IK, LEE S, et al. 1H-pyrrole-2,5-dione-based small molecule-induced generation of mesenchymal stem cell-derived functional endothelial cells that facilitate rapid endothelialization after vascular injury. Stem Cell Res Ther. 2015;6(1):174.
[25] 景涛,何国祥,苗莉,等.间充质干细胞移植实现AT2R基因在体可调控表达在再狭窄形成的作用及机制[J].中国介入心脏病学杂志, 2010,18(5):284-289.
[26] 王庆元,吴向军,张晓燕,等.骨髓间充质干细胞局部移植对兔腹主动脉成形术后再狭窄和平滑肌细胞增殖的影响[J].中国老年学杂志,2017,37(4):814-816.
[27] 刘志江,石蓓,许官学,等.骨髓间充质干细胞移植对兔颈动脉球囊损伤后再狭窄的影响[J].中国动脉硬化杂志,2013,21(1):22-27.
[28] 吴向军, 宋艳丽, 耿文真, 等.骨髓间充质干细胞移植对兔腹主动脉成形术后血管内膜的影响[J]. 中华老年心脑血管病杂志,2015, 17(6):634-637.
[29] 束波,范芳.基质细胞衍生因子1(SDF-1)预处理的骨髓间充质干细胞移植减轻大鼠颈动脉内皮和平滑肌细胞增生[J].细胞与分子免疫学杂志,2019,5(4):320-326.
[30] 赵然尊,龙仙萍,许官学,等.受体活性修饰蛋白-1转染间充质干细胞对兔血管成形术后血管平滑肌细胞增殖和凋亡的影响[J].中华老年医学杂志,2014,33(10):1127-1131.
[31] 龙仙萍,赵然尊,石蓓,等. hRAMP1修饰的骨髓间充质干细胞移植对兔球囊损伤血管再狭窄及心功能的影响[J].中华医学杂志, 2012,92(30):2134-2139.
[32] CHEN P, HE F, LIU T, et al. Construction of calcitonin gene-related peptide-modified mesenchymal stem cells and analysis of their effects on the migration and proliferation of vascular smooth muscle cells. In Vitro Cell Dev Biol Anim. 2020;56(2):181-191.
[33] CHANG HK, KIM PH, KIM DW, et al. Coronary stents with inducible VEGF/HGF-secreting UCB-MSCs reduced restenosis and increased re-endothelialization in a swine model. Exp Mol Med. 2018;50(9):114.
[34] KIM AK, KIM MH, KIM DH, et al. Inhibitory effects of mesenchymal stem cells in intimal hyperplasia after balloon angioplasty. J Vasc Surg. 2016;63(2):510-517.
[35] 郭艳,石蓓,王正龙,等.外周血间充质干细胞移植对球囊损伤兔血管平滑肌细胞凋亡的影响[J].中国生物医学工程学报,2010,29(2): 288-294.
[36] 郭艳,石蓓,赵然尊,等.外周血间充质干细胞移植防治兔血管成形术后再狭窄的探讨[J].中华老年心脑血管病杂志,2009,11(12):968-971.
[37] 石蓓,郭艳,王正龙,等.缺氧预处理外周间充质干细胞对兔血管成形术后再狭窄的影响[J].中国病理生理杂志,2009,25(9):1686-1691.
[38] HOMMA J, SEKINE H, MATSUURA K, et al. Mesenchymal Stem Cell Sheets Exert Antistenotic Effects in a Rat Arterial Injury Model. Tissue Eng Part A. 2018;24(19-20):1545-1553.
[39] CAI C, KILARI S, ZHAO C, et al. Therapeutic Effect of Adipose Derived Mesenchymal Stem Cell Transplantation in Reducing Restenosis in a Murine Angioplasty Model. J Am Soc Nephrol. 2020;31(8):1781-1795.
[40] 郑仕杰,周敬群,杨维华,等.血管损伤后TGF-β1/Smad信号通路在诱导BMSCs分化参与血管再狭窄的相关性研究[J].中国医药科学,2019,9(17):50-54.
[41] 魏翠蕾,邹泓,段军仓,等. TGF-β1/Smad信号通路的激活对招募间充质干细胞在血管损伤中的表达变化及意义[J].石河子大学学报(自然科学版),2014,32(6):720-726.
[42] PANG L, WEI C, DUAN J, et al. TGF-β1/Smad signaling, MMP-14, and MSC markers in arterial injury: discovery of the molecular basis of restenosis. Int J Clin Exp Pathol. 2014;7(6):2915-2924.
[43] ZHAO W, WANG C, LIU R, et al. Effect of TGF-β1 on the Migration and Recruitment of Mesenchymal Stem Cells after Vascular Balloon Injury: Involvement of Matrix Metalloproteinase-14. Sci Rep. 2016;6:21176.
[44] 刘志江,石蓓,许官学,等.CXCR4基因修饰骨髓间充质干细胞移植对损伤血管内皮化的影响[J].临床心血管病杂志,2014,30(12): 1094-1098.
[45] 刘志江,石蓓,许官学,等.骨髓间充质干细胞移植后颈动脉损伤球囊核转录因子κBp65和增殖细胞核抗原的表达[J].中国组织工程研究与临床康复,2011,15(10):1814-1818.
[46] SKERRETT IM, WILLIAMS JB. A structural and functional comparison of gap junction channels composed of connexins and innexins. Dev Neurobiol. 2017;77(5):522-547.
[47] LAO KH, ZENG L, XU Q. Endothelial and smooth muscle cell transformation in atherosclerosis. Curr Opin Lipidol. 2015;26(5):449-456.
[48] ZHANG Y, HU YW, ZHENG L, et al. Characteristics and Roles of Exosomes in Cardiovascular Disease. DNA Cell Biol. 2017;36(3):202-211.
[49] Pankajakshan D, Agrawal DK. Mesenchymal Stem Cell Paracrine Factors in Vascular Repair and Regeneration. J Biomed Technol Res. 2014;1(1):10.
[50] 王刚,时光旭,韩骅,等.内皮祖细胞来源外泌体在血管生成中作用的研究进展[J].心脏杂志,2019,31(5):588-591.
[51] 潘满昌,林晓莹,汪虹,等.血管内皮祖细胞源性外泌体在创面修复中的作用研究进展[J].中华烧伤杂志,2020,36(9):883-886.
[52] 谢川平,陈佳树,陈天,等.内皮祖细胞治疗脑创伤的研究进展[J].创伤外科杂志,2019,21(3):77-80.
[53] 郭桢楠,马雪,丁文刚.内皮祖细胞在急性肺损伤中应用的研究进展[J].中国现代医学杂志,2021,31(3):65-69.
[54] MALANEY P, UVERSKY VN, DAVÉ V. PTEN proteoforms in biology and disease. Cell Mol Life Sci. 2017;74(15):2783-2794.
[55] ZHANG X, LU A, LI Z, et al. Exosomes secreted by endothelial progenitor cells improve the bioactivity of pulmonary microvascular endothelial cells exposed to hyperoxia in vitro. Ann Transl Med. 2019;7(12):254.
[56] WU X, LIU Z, HU L, et al. Exosomes derived from endothelial progenitor cells ameliorate acute lung injury by transferring miR-126. Exp Cell Res. 2018;370(1):13-23.
[57] HERGENREIDER E, HEYDT S, TRÉGUER K, et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol. 2012;14(3):249-256.
[58] TOGLIATTO G, DENTELLI P, ROSSO A, et al. PDGF-BB Carried by Endothelial Cell-Derived Extracellular Vesicles Reduces Vascular Smooth Muscle Cell Apoptosis in Diabetes. Diabetes. 2018;67(4):704-716.
[59] LI B, ZANG G, ZHONG W, et al. Activation of CD137 signaling promotes neointimal formation by attenuating TET2 and transferrring from endothelial cell-derived exosomes to vascular smooth muscle cells. Biomed Pharmacother. 2020;121:109593.
[60] LIN X, LI S, WANG YJ, et al. Exosomal Notch3 from high glucose-stimulated endothelial cells regulates vascular smooth muscle cells calcification/aging. Life Sci. 2019;232:116582.
[61] 桑宏飞.内皮祖细胞对血管平滑肌细胞功能及静脉血栓后管壁重塑的影响[D].苏州:苏州大学,2014.
[62] 方立.内皮祖细胞对血管平滑肌细胞增殖与表型转化的抑制作用及其机制研究[D].长沙:湘雅医院,2010.
[63] LI X, CHEN C, WEI L, et al. Exosomes derived from endothelial progenitor cells attenuate vascular repair and accelerate reendothelialization by enhancing endothelial function. Cytotherapy. 2016;18(2):253-262.
[64] HU H, JIANG C, LI R, et al. Comparison of endothelial cell- and endothelial progenitor cell-derived exosomes in promoting vascular endothelial cell repair. Int J Clin Exp Pathol. 2019;12(7):2793-2800.
[65] HOU YC, LI JA, ZHU SJ, et al. Tailoring of cardiovascular stent material surface by immobilizing exosomes for better pro-endothelialization function. Colloids Surf B Biointerfaces. 2020;189:110831.
[66] KONG J, WANG F, ZHANG J, et al. Exosomes of Endothelial Progenitor Cells Inhibit Neointima Formation After Carotid Artery Injury. J Surg Res. 2018;232:398-407.
[67] HARRELL CR, JOVICIC N, DJONOV V, et al. Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases. Cells. 2019;8(12):1605.
[68] OTERO-ORTEGA L, GÓMEZ DE FRUTOS MC, LASO-GARCÍA F, et al. Exosomes promote restoration after an experimental animal model of intracerebral hemorrhage. J Cereb Blood Flow Metab. 2018;38(5):767-779.
[69] LIU H, LIANG Z, WANG F, et al. Exosomes from mesenchymal stromal cells reduce murine colonic inflammation via a macrophage-dependent mechanism. JCI Insight. 2019;4(24):e131273.
[70] YANG J, LIU XX, FAN H, et al. Extracellular Vesicles Derived from Bone Marrow Mesenchymal Stem Cells Protect against Experimental Colitis via Attenuating Colon Inflammation, Oxidative Stress and Apoptosis. PLoS One. 2015;10(10):e0140551.
[71] COSENZA S, RUIZ M, TOUPET K, et al. Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis. Sci Rep. 2017;7(1):16214.
[72] SONG Y, DOU H, LI X, et al. Exosomal miR-146a Contributes to the Enhanced Therapeutic Efficacy of Interleukin-1β-Primed Mesenchymal Stem Cells Against Sepsis. Stem Cells. 2017;35(5):1208-1221.
[73] SUZUKI E, FUJITA D, TAKAHASHI M, et al. Therapeutic Effects of Mesenchymal Stem Cell-Derived Exosomes in Cardiovascular Disease. Adv Exp Med Biol. 2017;998:179-185.
[74] DENG S, ZHOU X, GE Z, et al. Exosomes from adipose-derived mesenchymal stem cells ameliorate cardiac damage after myocardial infarction by activating S1P/SK1/S1PR1 signaling and promoting macrophage M2 polarization. Int J Biochem Cell Biol. 2019;114:105564.
[75] TENG X, CHEN L, CHEN W, et al. Mesenchymal Stem Cell-Derived Exosomes Improve the Microenvironment of Infarcted Myocardium Contributing to Angiogenesis and Anti-Inflammation. Cell Physiol Biochem. 2015;37(6):2415-2424.
[76] CHEN Q, LIU Y, DING X, et al. Bone marrow mesenchymal stem cell-secreted exosomes carrying microRNA-125b protect against myocardial ischemia reperfusion injury via targeting SIRT7. Mol Cell Biochem. 2020;465(1-2):103-114.
[77] LIANG X, ZHANG L, WANG S, et al. Exosomes secreted by mesenchymal stem cells promote endothelial cell angiogenesis by transferring miR-125a. J Cell Sci. 2016;129(11):2182-2189.
[78] KONG LY, LIANG MY, LIU JP, et al. Mesenchymal Stem Cell-derived Exosomes Rescue Oxygen-Glucose Deprivation-induced Injury in Endothelial Cells. Curr Neurovasc Res. 2020;17(2):155-163.
[79] WANG D, GAO B, YUE J, et al. Exosomes from mesenchymal stem cells expressing miR-125b inhibit neointimal hyperplasia via myosin IE. J Cell Mol Med. 2019;23(2):1528-1540.
[80] 龙禹哲,郭鸿浩,杨双亚,等.骨髓间充质干细胞源外泌体对大鼠颈动脉球囊损伤后lncRNAs表达的影响[J].第三军医大学学报, 2020,42(23):2320-2329.
[81] LIU Z, WU C, ZOU X, et al. Exosomes derived from mesenchymal stem cells inhibit neointimal hyperplasia by activating the Erk1/2 signalling pathway in rats. Stem Cell Res Ther. 2020;11(1):220.
[82] PHINNEY DG, PITTENGER MF. Concise Review: MSC-Derived Exosomes for Cell-Free Therapy. Stem Cells. 2017;35(4):851-858.
[83] WERNLY B, MIRNA M, REZAR R, et al. Regenerative Cardiovascular Therapies: Stem Cells and Beyond. Int J Mol Sci. 2019;20(6):1420. |